Author

Srinivas Bandari

Observed names: Bandari Srinivas, Bandari, Srinivas, Bandari. Srinivas, S. Bandari

Observed institution: Chaitanya

ORCID: 0000-0002-1161-9576

Observed ORCID: 0000-0002-1161-9576

OpenAlex ID: A5093881763

Design and synthesis of novel quinoxaline-piperazine linked isoxazole conjugates: Anti-cancer assessment, tyrosine kinase EGFR inhibitory activity, molecular docking and DFT studies

2024 · Sharada Ravula, Devender Banothu, et al. · Journal of Molecular Structure · 15

New quinoxaline‐piperazine‐oxazole conjugates: Synthesis, in vitro anticancer, in silico ADMET, and molecular docking studies

2024 · Mohammad Ferazoddin, Siddhartha Marupati, et al. · Journal of Heterocyclic Chemistry · 10

PDF

Design, Synthesis, in Silico Molecular Docking and ADMET Studies of Indole‐Sulfonamide Derivatives as Tubulin Polymerization Inhibiting Agents

2024 · Gouthami Dasari, Narasimha Swamy Thirukovela, et al. · ChemistrySelect · 5

New Quinoxaline Linked Fused Imidazo‐oxazole Conjugates as EGFR Inhibitors: Design, Synthesis, in Vitro Anti‐Breast Cancer Evaluation, Molecular Docking Studies and in Silico ADMET

2024 · Mohammad Ferazoddin, Arshiya Banu Syeda, et al. · ChemistrySelect · 4

Design and Synthesis of Some New Quinoxaline-1,2,4-triazole-3-amide Conjugates as Anticancer Agents

2024 · S. Ravula, S. Marupati, et al. · Russian Journal of General Chemistry · 4

Design and Synthesis of New 1,2,4-Triazolo-Thiadiazine-Quinoxalin-2(1 H )-One Conjugates as EGFR Targeting Agents

2025 · Vasavi Katti, Gouthami Dasari, et al. · Polycyclic aromatic compounds · 3

Design and Synthesis of New Quinoxaline‐Oxazole‐Morpholino Conjugates; Evaluation of Anticancer Activity and In Silico Molecular Docking and ADMET Studies

2024 · Yellaiah Bonakolluru, Siddhartha Marupati, et al. · ChemistrySelect · 3

Synthesis of new quinazoline-linked fused imidazole-oxazole conjugates; evaluation of anticancer activity, molecular docking, DFT and ADMET studies

2026 · Devula Venkata. Nagarajesh, Dasari. Gouthami, et al. · Results in Chemistry · 2

Design and Synthesis of Indole-oxazole-benzamide Conjugates; In Vitro Anticancer Evaluation and ADMET Studies

2025 · P. Kandukuri, K. Tula, et al. · Russian Journal of General Chemistry · 2

Design, Synthesis, In Vitro Anticancer and ADMET Studies of Piperazine-Pyrazolo-Quinoxalin-2(1H)-one Conjugate as EGFR Targeting Agents

2025 · M. Ferazoddin, Arshiya Banu Syeda, et al. · Russian Journal of General Chemistry · 1

Synthesis and Biological Activities of New 3-Amino Derivatives of Methyl 2-oxo-1-(2,2,2-trifluoroethyl)-1,2-dihydroquinoxaline-6-carboxylate

2026 · Puttapaka Vijay Kumar, Bandari Srinivas, et al. · Asian Journal of Chemistry

PDF

Design, Synthesis and Characterisation of New Trifluoroethyl Dihydroquinoxaline Carboxylate Amino Derivatives and Evaluation of their Biological Activities

2026 · Puttapaka Vijay Kumar, Dasa Prakash, et al. · Asian Journal of Chemistry

PDF

Green Catalytic Pathways for Sustainable Organic Synthesis: Advances and Challenges

2026 · Bandari Srinivas, Yallaboina Mahesh, et al. · International Journal of Life Sciences

PDF

Design and Synthesis of 1,2,3-Triazole-quinazoline-acetamide Hybrids; Evaluation of Anticancer Activity and ADMET Analysis

2026 · Devula Venkata Nagarajesh, Dasari Gouthami, et al. · Russian Journal of General Chemistry

Design and Synthesis of New Quinazoline Hybrid Molecules as EGFR Targeting Anti‐Breast Cancer Agents

2026 · Pandaga Saidulu, Srinivas Bandari, et al. · ChemistrySelect

Design and Synthesis of Fused 1,2,3-Triazolo-Pyrano-Quinazoline Using Copper(I) Catalysis: In silico Molecular Docking, in vitro Tyrosine Inhibition and ADMET Studies

2025 · Saidi Reddy Modugu, Gouthami Dasari, et al. · Asian Journal of Chemistry

PDF

Design and Synthesis of New 1,2,4-Triazolo-Thiadiazine-Quinoxalin-2(1H)-One Conjugates as EGFR Targeting Agents

2025 · Katti, Vasavi, Dasari, Gouthami, et al. · Figshare

Works count: 17

Citation count: 49

H-index: 4

I10-index: 2